menu search

Labcorp (lh) launches biomarker test for alzheimer's disease

Labcorp's (LH) new test, ATN Profile, is likely to accelerate the path to the diagnosis of alzheimer's ...

October 13, 2023, 9:46 am

Tiziana life sciences reveals positive pet scan results with foralumab to treat ms patients

Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that a reduction in activated microglia, as seen in six-month Positron Emission Tomography (PET) s...

October 13, 2023, 8:34 am

Cassava sciences slumps after leak claims “egregious misconduct”

Cassava Sciences Inc has denied data manipulation after a probe into conduct over its alzheimer's drug ...

October 13, 2023, 5:29 am

Labcorp launches 3-part blood test for alzheimer's

Labcorp on Wednesday began marketing to U.S. physicians the first test for a trio of blood biomarkers it says can detect the hallmarks of ...

October 11, 2023, 7:34 am

Anavex: the september data

Anavex Life Sciences Corp. presented follow-on data from its alzheimer's disease trial. This data uses ...

October 9, 2023, 11:37 am

Novartis leads funding round for uk alzheimer's specialist

UK-based biotech firm AstronauTx has secured £48 million ($61 million) in a significant Series A funding round, marking a step towards developing tre...

October 9, 2023, 2:16 am

Neurosense: a hold ahead of phase 2b als data

NeuroSense Therapeutics will report Phase 2b trial data for its ALS drug candidate, PrimeC, in Q4 2023. Topline data of this trial may well be the com...

October 6, 2023, 6:51 pm

Why shares of cassava sciences soared this week

A rash of insider buying helped buoy the clinical-stage biotech's stock. Cassava said it had completed the enrollment of a phase 3 trial for an ...

October 6, 2023, 3:13 pm

Longeveron stock jumps on alzheimer's trial results

Longeveron Inc. shares LGVN, +4.58% jumped 16% premarket on Thursday after the clinical-stage biotech company announced positive results from a trial ...

October 5, 2023, 8:13 am

Radnet stock: bullish with several growth tailwinds for diagnostic imaging

RadNet is capturing a strong demand for diagnostic imaging which benefits from several secular growth trends. The approval of new ...

October 4, 2023, 4:45 pm

Navigating acumen's alzheimer's risk and reward

Acumen Pharmaceuticals' ACU193 shows promise as a potential treatment for early-stage alzheimer's Disea...

October 3, 2023, 11:03 am

Acumen pharmaceuticals: novel alzheimer's molecule with positive early data

Acumen Pharmaceuticals is developing a monoclonal antibody, ACU193, that targets Amyloid beta oligomers (AβOs) in ...

October 3, 2023, 5:15 am

Newamsterdam pharma's pioneering pulse on alzheimer's breakthroughs

New clinical data shows the potential of obicetrapib in treating early alzheimer's disease in patients ...

October 2, 2023, 9:26 pm

Ionis (ions) inks new deal with roche to develop novel rna drugs

Per the agreement, Ionis (IONS) will grant exclusive global rights to Roche to develop and market two novel RNA-therapeutics for ...

September 28, 2023, 11:17 am

Biovie complements its alzheimer's clinical research program with social impact initiatives

What sets BioVie Inc (NASDAQ:BIVI) apart from many of its biotechnology peers is the fact it has appointed a Chief Social Impact Officer whose role is...

September 26, 2023, 3:29 pm

Biovie to announce topline data from phase 3 alzheimer's disease trial by year-end

BioVie Inc (NASDAQ:BIVI) said the last patient has completed their final visit at week 30 in their Phase 3 study of investigational therapy NE3107 in...

September 26, 2023, 9:11 am

Leqembi® intravenous infusion (lecanemab) approved for the treatment of alzheimer’s disease in japan

TOKYO and CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (...

September 25, 2023, 5:02 am

Japan approves alzheimer treatment leqembi by eisai and biogen

Japan's Eisai said on Monday the country's health ministry had approved its alzheimer treatment Leqembi...

September 25, 2023, 1:16 am

Prothena: switching from 'hold' to 'buy' on lead alzheimer's drug promise

Prothena Corporation is a protein dysregulation specialist with a focus on developing drugs for alzheimer...

September 21, 2023, 1:39 pm

Acumen pharmaceuticals to participate in the cantor global healthcare conference

CHARLOTTESVILLE, Va. and CARMEL, Ind., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceuti...

September 19, 2023, 4:00 pm


Search within

Pages Search Results: